Shannon Colin

President & CEO, DirectorPRA Health Sciences, Inc. (PRAH) · full profile →Form 4/A · filed Jun 30, 2021
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.4M
Net Open-Market Flow
-$1.4M
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 16, 2021Sell(S)564$167.39$94K47K
Jun 16, 2021Sell(S)430$168.13$72K47K
Jun 16, 2021Sell(S)7K$166.42$1.2M47K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4/A filing (accession 0001104659-21-087297) within minutes of acceptance. Every field above traces to the original document. Verify it directly: